Boston Scientific (BSX) Posts Q3 EPS of $0.19; Revs Beat; Guides Q4, FY10 EPS and Revs
Boston Scientific (NYSE: BSX) reports Q3 EPS of $0.19, which may not compare to the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
